Concentra Group Holdings (NYSE:CON) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here's what investors need to know before the announcement.
Analysts estimate that Concentra Group Holdings will report an earnings per share (EPS) of $0.26.
Concentra Group Holdings bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
The company's EPS beat by $0.02 in the last quarter, leading to a 3.37% increase in the share price on the following day.
Here's a look at Concentra Group Holdings's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.37 | 0.37 | 0.32 | 0.17 |
| EPS Actual | 0.39 | 0.37 | 0.32 | 0.17 |
| Price Change % | 3.37 | 7.03 | -3.48 | 0.27 |

Shares of Concentra Group Holdings were trading at $23.41 as of February 24. Over the last 52-week period, shares are up 2.25%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Concentra Group Holdings's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 16.98%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Concentra Group Holdings's net margin is impressive, surpassing industry averages. With a net margin of 8.33%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Concentra Group Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 13.1%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Concentra Group Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.68%, the company showcases efficient use of assets and strong financial health.
Debt Management: Concentra Group Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 5.55. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
This article was generated by Benzinga's automated content engine and reviewed by an editor.